• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    McKesson Corporation Declares Quarterly Dividend

    5/1/25 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care
    Get the next $MCK alert in real time by email

    The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on July 1, 2025, to stockholders of record on June 2, 2025.

    About McKesson Corporation

    McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250430682101/en/

    Investors

    [email protected]

    Media Relations

    [email protected]

    Get the next $MCK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MCK

    DatePrice TargetRatingAnalyst
    12/4/2024$630.00Neutral
    Mizuho
    11/7/2024$531.00 → $688.00Neutral → Outperform
    Robert W. Baird
    9/24/2024$603.00 → $531.00Outperform → Neutral
    Robert W. Baird
    9/5/2024$670.00 → $665.00Outperform
    Leerink Partners
    8/8/2024$540.00 → $570.00Neutral
    Mizuho
    2/26/2024$600.00Outperform
    Leerink Partners
    1/3/2024$537.00Overweight
    Barclays
    12/14/2023$502.00Equal Weight
    Wells Fargo
    More analyst ratings

    $MCK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Tyler Brian S. gifted 4,000 shares, decreasing direct ownership by 8% to 47,243 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      6/11/25 2:05:11 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Tyler Brian S. sold $13,673,864 worth of shares (19,370 units at $705.93), decreasing direct ownership by 27% to 51,243 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      6/9/25 3:28:44 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • EVP, Chief Strategy & BDO Rodgers Thomas L sold $2,058,912 worth of shares (2,891 units at $712.18), decreasing direct ownership by 53% to 2,544 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      6/2/25 6:40:36 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $MCK
    SEC Filings

    See more
    • McKesson Corporation filed SEC Form 8-K: Regulation FD Disclosure

      8-K - MCKESSON CORP (0000927653) (Filer)

      6/9/25 8:00:02 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 144 filed by McKesson Corporation

      144 - MCKESSON CORP (0000927653) (Subject)

      5/30/25 10:27:36 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Corporation filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

      8-K - MCKESSON CORP (0000927653) (Filer)

      5/30/25 10:15:08 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care